Here is a comprehensive breakdown of preoperative tests used to predict PPCs (excluding CPET), with evidence-based guidance on which to use, when, and their limitations:
Preoperative Tests for Predicting PPCs (Excluding CPET)
1. Pulse Oximetry (SpO2)
What it measures: Resting oxygen saturation on room air, in the supine position.
Role in PPC prediction: This is one of the strongest and most practical predictors of PPCs. It is a core component of the ARISCAT score - one of the most validated PPC risk tools available.
| Preoperative SpO2 | ARISCAT Risk Points | Odds Ratio for PPCs |
|---|
| ≥96% | 0 | Reference |
| 91-95% | 8 | OR 2.2 (95% CI 1.2-4.2) |
| ≤90% | 24 | OR 10.7 (95% CI 4.1-28.1) |
Recommendation: Obtain in ALL preoperative patients; it is non-invasive, inexpensive, and highly informative. Measure supine and on room air for accuracy.
(Murray & Nadel's Textbook of Respiratory Medicine; Fischer's Mastery of Surgery, 8e)
2. Spirometry / Pulmonary Function Tests (PFTs)
What it measures: FEV1, FVC, FEV1/FVC ratio, MVV, FEF25-75%, DLCO (diffusing capacity).
Role in PPC prediction:
- Lung resection (thoracic surgery): Spirometry and DLCO are mandatory and well-validated. Key thresholds before resection:
- FEV1 <2 L or <80% predicted - elevated risk
- MVV <50% predicted
- ppoFEV1 <40% - high risk for resection
- DLCO <40% predicted - contraindication to pneumonectomy
- Noncardiothoracic surgery: Spirometry adds limited incremental value beyond clinical history and physical exam. A 2022 systematic review (Dankert et al., PMID 34939921) concluded that evidence for PFTs in non-thoracic surgery remains weak, though subgroup analysis suggests benefit in upper abdominal surgery.
When spirometry IS indicated (Fischer's Mastery of Surgery 8e; Harrison's, 22e):
- All patients undergoing lung resection
- Suspected but undiagnosed COPD
- Known COPD/asthma where baseline function cannot be assessed clinically
- Patients with symptoms disproportionate to their known disease
When spirometry is NOT routinely recommended (Murray & Nadel; Harrison's 22e):
- Asymptomatic patients
- Cardiac surgery without new/worsened cardiopulmonary symptoms ("Choosing Wisely" recommendation)
- General elective surgery without pulmonary comorbidities
Key caveat: Abnormal spirometry does correlate with PPCs but does not clearly provide additional risk prediction above a careful history and exam in most noncardiothoracic surgery patients.
3. Chest Radiograph (CXR)
Role in PPC prediction: CXR abnormalities are associated with PPCs, but routine screening CXRs in asymptomatic patients are not recommended (Maingot's Abdominal Operations; Fischer's Mastery of Surgery 8e).
Indications for preoperative CXR per ACP and ACC/AHA:
- History of known cardiopulmonary disease
- Age ≥50 undergoing upper abdominal, thoracic, or aortic surgery
- Severe obesity (BMI >40 kg/m2) - to screen for undiagnosed CHF, pulmonary HTN, or cardiomegaly
- Clinical suspicion of infection or bullous emphysema
- Abnormal findings on physical exam
What to look for: Hyperinflation, consolidation, pleural effusion, cardiomegaly, pulmonary vascular congestion, atelectasis, masses.
Limitation: Low incremental predictive value in the absence of clinical abnormality; rarely changes management in already-assessed patients.
4. Arterial Blood Gas (ABG)
What it measures: PaO2, PaCO2, pH, bicarbonate, base excess.
Relevant thresholds:
- PaO2 <60 mmHg on room air - increased PPC risk
- PaCO2 ≥45 mmHg - associated with increased perioperative risk, especially for thoracic surgery (Cummings Otolaryngology; Maingot's Abdominal Operations)
- Elevated serum HCO3- in patients with suspected OSA - suggests chronic CO2 retention and possible obesity hypoventilation syndrome (OHS), which substantially increases risk
Role in PPC prediction:
- Lung resection: Provides useful baseline for patients with chronic CO2 retention.
- Noncardiothoracic surgery: Limited value - hypercapnia is usually clinically apparent and ABG rarely alters management (Murray & Nadel's). A 2025 study (IJCMAAS) found ABG was a poor predictor in elective abdominal surgery (AUC 0.611, non-significant).
- Suspected OSA: Elevated serum bicarbonate on routine labs is a reasonable surrogate; if elevated, consider full ABG.
When ABG is useful preoperatively:
- Thoracic surgery and lung resection planning
- New or worsened respiratory symptoms requiring workup
- Suspected OHS or severe COPD (to guide postoperative ventilation planning)
5. Serum Albumin
What it measures: Nutritional status and systemic inflammatory state; normal ≥3.5 g/dL (≥35 g/L).
Role in PPC prediction: Low albumin is a consistently identified independent risk factor for PPCs across multiple models.
- Albumin <3.5 g/dL: OR 2.53 for pulmonary complications (Miller's Anesthesia 10e)
- Included as a risk factor in the ACP 2006 guidelines and Arozullah respiratory failure index
- Hypoalbuminemia reflects poor nutritional reserve, impaired respiratory muscle strength, and reduced immune defense against pneumonia
Recommendation: Obtain in patients undergoing major abdominal, thoracic, or vascular surgery, especially elderly or malnourished patients.
6. Blood Urea Nitrogen (BUN)
What it measures: Renal function and indirect marker of catabolism/dehydration.
Role in PPC prediction:
- Elevated BUN >7.5 mmol/L (>21 mg/dL): OR 4.81 for pulmonary complications (Miller's Anesthesia 10e)
- Included in some PPC risk models as a marker of end-organ dysfunction
- Additive value above clinical assessment is uncertain (Murray & Nadel's)
7. Hemoglobin / Complete Blood Count (CBC)
What it measures: Anemia, baseline hematologic status.
Role in PPC prediction:
- Hemoglobin ≤10 g/dL is one of the 7 variables in the ARISCAT score (11 risk points; OR 3.0 for PPCs)
- Anemia impairs oxygen-carrying capacity and reduces physiologic reserve, predisposing to hypoxemia after surgery
- Preoperative WBC and neutrophil ratio are emerging ML model predictors in thoracoscopic surgery populations
Recommendation: Obtain CBC in all moderate-to-high-risk surgical patients; hemoglobin is both a predictor and an optimizable variable.
8. Serum Bicarbonate (HCO3-)
A less discussed but practical test: elevated HCO3- in patients with suspected or known OSA suggests chronic CO2 retention and possible OHS. The Society of Anesthesia and Sleep Medicine (SASM) recommends delaying nonurgent surgery in such patients for further workup, as perioperative complication risk is substantially higher (Murray & Nadel's).
9. Lung Ultrasound (LUS)
Emerging role: Point-of-care preoperative lung ultrasound can detect occult pleural effusions, interstitial syndrome, consolidation, and reduced diaphragmatic excursion that may not be apparent clinically or on CXR. The Lung Ultrasound Score (LUS) as a perioperative PPC predictor is an active research area (Vetrugno et al., 2026, European Journal of Anaesthesiology [PMID 41340139]) though its additive value over clinical risk scores remains under investigation.
10. Ventilation-Perfusion (V/Q) Scan and Quantitative CT
For lung resection candidates only:
- Quantitative CT volumetry can calculate predicted postoperative lung function (ppoFEV1, ppoDLCO) based on regional lung contribution
- V/Q scintigraphy (SPECT): Measures fractional contribution of each lung segment; used when CT is not available or when regional assessment is needed
- Both are superior to simple spirometric thresholds for estimating functional reserve after resection
Summary: When to Use Which Test
| Test | Routine All Surgery | Upper Abdo/Thoracic | Lung Resection | COPD/Asthma | OSA Suspected |
|---|
| Pulse oximetry | YES | YES | YES | YES | YES |
| Spirometry (FEV1/FVC) | No | Consider | Mandatory | If uncontrolled | No |
| DLCO | No | No | Mandatory | Rarely | No |
| Chest X-ray | No (if asymptomatic) | YES (age ≥50) | YES | If uncontrolled | No |
| ABG | No | Selected | YES | Severe/CO2 retainer | If HCO3- elevated |
| Serum albumin | No | YES | YES | No | No |
| BUN | No | Consider | Consider | No | No |
| Hemoglobin/CBC | Moderate-high risk | YES | YES | YES | No |
| Serum HCO3- | Screen for OSA | No | No | No | YES |
| Lung ultrasound | No | Emerging | Emerging | No | No |
| Quantitative CT/V/Q | No | No | Lung resection | No | No |
Bottom line from the evidence: The best-performing preoperative tests for PPC prediction are pulse oximetry (SpO2) and serum hemoglobin - both incorporated into ARISCAT. Spirometry adds value primarily for thoracic surgery and suspected COPD. ABG, albumin, and BUN contribute to risk models but rarely change management when clinical assessment is thorough. The general principle (Harrison's 22e; Murray & Nadel's) is: preoperative labs and imaging should not be ordered routinely but targeted to patient risk and surgical procedure.